C

CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765

Watchlist Manager
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Watchlist
Price: 26.8 CNY 2.6% Market Closed
Market Cap: 71.6B CNY
Have any thoughts about
CSPC Innovation Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
CSPC Innovation Pharmaceutical Co Ltd

Wall Street analysts forecast CSPC Innovation Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSPC Innovation Pharmaceutical Co Ltd is 41.89 CNY with a low forecast of 37.37 CNY and a high forecast of 47.25 CNY.

Lowest
Price Target
37.37 CNY
39% Upside
Average
Price Target
41.89 CNY
56% Upside
Highest
Price Target
47.25 CNY
76% Upside
CSPC Innovation Pharmaceutical Co Ltd Competitors:
Price Targets
ROVI
Laboratorios Farmaceuticos ROVI SA
51% Upside
AMLX
Amylyx Pharmaceuticals Inc
100% Upside
LQDA
Liquidia Corp
126% Upside
4521
Kaken Pharmaceutical Co Ltd
17% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
96% Upside
GLS
Glenmark Life Sciences Ltd
15% Upside
CRDL
Cardiol Therapeutics Inc
453% Upside
4536
Santen Pharmaceutical Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 4 years is 43%.

16%
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 24%.

21%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 11%.

25%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSPC Innovation Pharmaceutical Co Ltd's stock price target?
Price Target
41.89 CNY

According to Wall Street analysts, the average 1-year price target for CSPC Innovation Pharmaceutical Co Ltd is 41.89 CNY with a low forecast of 37.37 CNY and a high forecast of 47.25 CNY.

What is CSPC Innovation Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
43%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 4 years is 43%.

What is CSPC Innovation Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 24%.

What is CSPC Innovation Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
11%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 11%.

Back to Top